Gout Trial, Recruiting (NCT05507723)

Gout Trial, Recruiting NCT05507723 Sponsor: University of Edinburgh Condition: Gout

Printed from Voxsanity (voxsanity.com.au) — NCT05507723 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gout

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give your consent to take part in the trial.
You are 18 years old or older.
You have had at least one gout flare-up (attack) in the past 12 months.
You have been formally diagnosed with gout based on recognised medical guidelines.
Your blood uric acid level is above a certain threshold (confirm with trial site for exact value).
You own a smartphone and are able to download and install an app called GoutSMART.

Who may not be able to join:

You are not able to give your consent to take part.
You are already on the highest possible dose of uric acid-lowering medication, or you cannot take higher doses because you have had a bad reaction to the medicines allopurinol or febuxostat.
You have end-stage kidney failure or have had a kidney transplant.
You are currently taking certain medicines that are known to interact with gout medications, such as azathioprine or mercaptopurine (confirm with trial site if you are unsure whether your medicines are affected).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philip L Riches, FRCP, PhD, NHS Lothian

Phone: +44 7944625313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05507723

Sponsor: University of Edinburgh

Phase: Not Applicable

Status: Recruiting

Condition: Gout

Trial contact: +44 7944625313

More information: https://clinicaltrials.gov/study/NCT05507723

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give your consent to take part in the trial.
You are 18 years old or older.
You have had at least one gout flare-up (attack) in the past 12 months.
You have been formally diagnosed with gout based on recognised medical guidelines.
Your blood uric acid level is above a certain threshold (confirm with trial site for exact value).
You own a smartphone and are able to download and install an app called GoutSMART.

Who may not be able to join:

You are not able to give your consent to take part.
You are already on the highest possible dose of uric acid-lowering medication, or you cannot take higher doses because you have had a bad reaction to the medicines allopurinol or febuxostat.
You have end-stage kidney failure or have had a kidney transplant.
You are currently taking certain medicines that are known to interact with gout medications, such as azathioprine or mercaptopurine (confirm with trial site if you are unsure whether your medicines are affected).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Edinburgh

Registry

ClinicalTrials.gov

Start date

12 June 2025

Est. completion

31 May 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Proportion of participants flare free in 2nd year of trial

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov